Lam Research Corp. (NASDAQ:LRCX) stock rose nearly 3% Tuesday as semiconductor stocks, (including rival semiconductor manufacturing equipmentproviders KLA Corp. (NASDAQ: KLAC), Applied Materials, Inc. (NASDAQ:AMAT), ASML Holding N.V. (NASDAQ:ASML)) rebounded, while investors continued to weigh the company’s record September-quarter results, stronger-than-expected guidance and supply constraints that limited near-term upside.
Technology stocks gained 1.32%, while the S&P 500 rose 0.24%.
On CNBC’s "Mad Money," Jim Cramer said Lam is his preferred name over KLA, but warned that semiconductor-equipment stocks remain in a sharp selloff and said he would wait for clearer signs of stabilization before buying aggressively.
Lam Research stock gained over 36% in 2026 versus PHLX Semiconductor Index’s over 50% returns.
In October, Lam reported fiscal first-quarter revenue of $8.22 billion, above the $8.15 billion consensus, while adjusted EPS of $2.20 topped the $2.18 estimate.
CEO Tim Archer said AI-driven semiconductor demand and greater device complexity helped Lam deliver record revenue, profit and EPS.
Gross margin reached a record 52.4%, while operating margin exceeded 40% for the first time. Lam also generated a record $3.24 billion in free cash flow and raised its quarterly dividend 27% to 33 cents.
Lam expects second-quarter revenue of $8.2 billion-$9.0 billion, with the $8.6 billion midpoint slightly above consensus.
The company guided adjusted EPS to $2.18-$2.48, compared with the $2.31 analyst estimate.
Management also said some December-quarter shipments were delayed by component shortages and should shift into the March quarter.
China represented 35% of September revenue, but management expects that contribution to decline meaningfully in December as domestic Chinese spending slows.
Cantor Fitzgerald analyst C.J. Muse maintained an Overweight rating and a $500 price forecast, keeping Lam on the firm’s Top Pick list.
Muse said the quarter and guidance were solid, although the outlook fell short of more aggressive buy-side expectations.
He argued that supply constraints, rather than weaker demand, are limiting Lam’s near-term revenue.
Cantor also highlighted management’s preliminary forecast for roughly $200 billion in 2027 wafer-fab-equipment spending, up from about $155 billion in 2026.
Muse models $215 billion, while industry checks suggest spending could reach as high as $225 billion.
He also raised his 2027 EPS estimate to $10.75 from $10.25 and expects Lam’s tool business to grow about 50% in 2026 versus roughly 40% for the broader industry.
Other firms remained constructive but reduced price targets following the report.
Needham analyst Charles Shi maintained Buy and lowered his target to $290 from $390.
Mizuho analyst Vijay Rakesh maintained Outperform and cut his target to $360 from $365.
Morgan Stanley analyst Shane Brett maintained Overweight and lowered his target to $339 from $385.
LRCX Stock Price Activity: Lam Research shares were up 2.58% at $233.44 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo via Shutterstock